European Parliament report urges for reassessment of Urban Wastewater Treatment Directive’s impact on medicines
Europe must act now to protect patients and medicines supply
Medicines for Europe Letter on the Implementation of the Bolar Provision in Ukraine
Press statement following meeting with Commission President Ursula von der Leyen on tariffs
New Horizons for Biosimilar Medicines Policy: Delivering better access, outcomes, and biotech manufacturing in the future
EU multiannual financial framework funding for critical medicines manufacturing vital for strategic autonomy
IGBA Statement on trade barriers and their impact on healthcare systems and patients’ health
Ambitious Critical Medicines Act vital to secure supply
Medicines for Europe supports legal action against provisions in the Urban Wastewater Treatment Directive (UWWTD), which puts access to medicines at risk
Pharma reform brings new opportunities for better regulation, access and security of medicines supply
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
